Key statistics
On Friday, Enovis Corp (ENOV:NYQ) closed at 43.67, 9.23% above its 52-week low of 39.98, set on Aug 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 44.71 |
---|---|
High | 44.87 |
Low | 43.42 |
Bid | 42.21 |
Offer | 45.25 |
Previous close | 45.02 |
Average volume | 751.05k |
---|---|
Shares outstanding | 55.85m |
Free float | 55.32m |
P/E (TTM) | -- |
Market cap | 2.44bn USD |
EPS (TTM) | -1.96 USD |
Data delayed at least 15 minutes, as of Sep 21 2024 00:00 BST.
More ▼
- Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
- Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
- Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
- Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
- Enovis to Participate in Upcoming Investor Conferences
- Enovis Announces Second Quarter 2024 Results
- Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
- Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
- Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®
- Enovis Announces First Quarter 2024 Results
More ▼